Israel Active

I reported previously on Israel’s Medaware and its medication error protection system. The potentially life-saving solution has just been implemented at Assuta hospital in Ashdod. It is already deployed at Sheba medical center in Tel Hashomer.

Bacteria such as salmonella use a layer of biofilm to attach themselves to surfaces such as skin, medical devices, tissues, etc. Scientists at Israel’s Technion Institute used Alzheimer’s treatments to disrupt the biofilms. The salmonella virus couldn’t stick to the surfaces and became much less aggressive.

Israel’s Igentify develops a digital genetic testing analyzer that can provide medical professionals with the means to focus on, treat and counsel high risk patients. Already in use in two major Israeli hospitals, Igentify has just raised $10.5 million including from crowdfunding company OurCrowd.

Surgeons have now used the Dreal system from Israel’s Carevature in over 1600 spine decompression procedures. The system helps remove the minimum amount of obstructing tissue, reducing patient trauma and speeding recovery. Now available at Scripps Green hospital in California.

The Wall St Journal reports that Israel is becoming a testing ground for the power of artificial intelligence to improve health care. It suggests that digitized records and big data could make medicine cheaper and more effective.

In an Israeli first, two women have each been given a 3D printed titanium alloy implant to replace a broken talus (the main connector between the foot and leg). Doctors at Beilinson Hospital in Petah Tikva are confident that both women will soon be walking normally again.

I reported previously on the Namodenoson (CF102) liver cancer treatment from Israel’s Can-Fite. After Phase 2 testing, a supply of CF102 has been manufactured for “compassionate use” on critically ill patients at Rabin Medical Center in Petah Tikva.

Dvir Schnerb was released from hospital two weeks after being critically wounded by a terrorist bomb that killed his sister. A few hours later he received his certification as a volunteer EMT for Magen David Adom. He said he will honor his sister’s memory by working to save lives.

Israel’s MDClone system generates anonymous medical research data from real medical records. Customers include Israeli health companies Maccabi and Clalit and (in the US) Washington University hospital and Intermountain. MDClone has just raised $26 million of funds.

Every year the Israel Cancer Research Fund (ICRF) awards grants to Israeli researchers working to find cures and treatments for cancer. This year its 69 grants of $4.3 million focus on cancer genetics, targeted cancer therapies and immunotherapy. Read about some of the amazing work.